Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 8/2013

Open Access 01-08-2013 | Position Paper

Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle

Authors: K. Åkesson, D. Marsh, P. J. Mitchell, A. R. McLellan, J. Stenmark, D. D. Pierroz, C. Kyer, C. Cooper, IOF Fracture Working Group

Published in: Osteoporosis International | Issue 8/2013

Login to get access

Abstract

Summary

The International Osteoporosis Foundation (IOF) Capture the Fracture Campaign aims to support implementation of Fracture Liaison Services (FLS) throughout the world.

Introduction

FLS have been shown to close the ubiquitous secondary fracture prevention care gap, ensuring that fragility fracture sufferers receive appropriate assessment and intervention to reduce future fracture risk.

Methods

Capture the Fracture has developed internationally endorsed standards for best practice, will facilitate change at the national level to drive adoption of FLS and increase awareness of the challenges and opportunities presented by secondary fracture prevention to key stakeholders. The Best Practice Framework (BPF) sets an international benchmark for FLS, which defines essential and aspirational elements of service delivery.

Results

The BPF has been reviewed by leading experts from many countries and subject to beta-testing to ensure that it is internationally relevant and fit-for-purpose. The BPF will also serve as a measurement tool for IOF to award ‘Capture the Fracture Best Practice Recognition’ to celebrate successful FLS worldwide and drive service development in areas of unmet need. The Capture the Fracture website will provide a suite of resources related to FLS and secondary fracture prevention, which will be updated as new materials become available. A mentoring programme will enable those in the early stages of development of FLS to learn from colleagues elsewhere that have achieved Best Practice Recognition. A grant programme is in development to aid clinical systems which require financial assistance to establish FLS in their localities.

Conclusion

Nearly half a billion people will reach retirement age during the next 20 years. IOF has developed Capture the Fracture because this is the single most important thing that can be done to directly improve patient care, of both women and men, and reduce the spiralling fracture-related care costs worldwide.
Appendix
Available only for authorised users
Literature
1.
2.
3.
McLellan AR, Gallacher SJ, Fraser M, McQuillian C (2003) The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 14:1028–1034PubMedCrossRef
4.
Wright SA, McNally C, Beringer T, Marsh D, Finch MB (2005) Osteoporosis fracture liaison experience: the Belfast experience. Rheumatol Int 25:489–490PubMedCrossRef
5.
Clunie G, Stephenson S (2008) Implementing and running a fracture liaison service: an integrated clinical service providing a comprehensive bone health assessment at the point of fracture management. J Orthop Nurs 12:156–162CrossRef
6.
Premaor MO, Pilbrow L, Tonkin C, Adams M, Parker RA, Compston J (2010) Low rates of treatment in postmenopausal women with a history of low trauma fractures: results of audit in a Fracture Liaison Service. QJM 103:33–40PubMedCrossRef
7.
Wallace I, Callachand F, Elliott J, Gardiner P (2011) An evaluation of an enhanced fracture liaison service as the optimal model for secondary prevention of osteoporosis. JRSM Short Rep 2:8PubMedCrossRef
8.
Boudou L, Gerbay B, Chopin F, Ollagnier E, Collet P, Thomas T (2011) Management of osteoporosis in fracture liaison service associated with long-term adherence to treatment. Osteoporos Int 22:2099–2106PubMedCrossRef
9.
Huntjens KM, van Geel TA, Blonk MC, Hegeman JH, van der Elst M, Willems P et al (2011) Implementation of osteoporosis guidelines: a survey of five large fracture liaison services in the Netherlands. Osteoporos Int 22:2129–2135PubMedCrossRef
10.
Cooper MS, Palmer AJ, Seibel MJ (2012) Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study. Osteoporos Int 23:97–107PubMedCrossRef
11.
Inderjeeth CA, Glennon DA, Poland KE, Ingram KV, Prince RL, Van VR et al (2010) A multimodal intervention to improve fragility fracture management in patients presenting to emergency departments. Med J Aust 193:149–153PubMed
12.
Lih A, Nandapalan H, Kim M, Yap C, Lee P, Ganda K et al (2011) Targeted intervention reduces refracture rates in patients with incident non-vertebral osteoporotic fractures: a 4-year prospective controlled study. Osteoporos Int 22:849–858PubMedCrossRef
13.
Bogoch ER, Elliot-Gibson V, Beaton DE, Jamal SA, Josse RG, Murray TM (2006) Effective initiation of osteoporosis diagnosis and treatment for patients with a fragility fracture in an orthopaedic environment. J Bone Joint Surg Am 88:25–34PubMedCrossRef
14.
Sander B, Elliot-Gibson V, Beaton DE, Bogoch ER, Maetzel A (2008) A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs. J Bone Joint Surg Am 90:1197–1205PubMedCrossRef
15.
Dell R, Greene D, Schelkun SR, Williams K (2008) Osteoporosis disease management: the role of the orthopaedic surgeon. J Bone Joint Surg Am 90(Suppl 4):188–194PubMedCrossRef
16.
Greene D, Dell RM (2010) Outcomes of an osteoporosis disease-management program managed by nurse practitioners. J Am Acad Nurse Pract 22:326–329PubMedCrossRef
17.
18.
National Institute for Health and Clinical Excellence (2008) Alendronate (review), etidronate (review), risedronate (review), raloxifene (review) strontium ranelate and teriparatide (review) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. Technology Appraisal 161. NICE, London
19.
National Institute for Health and Clinical Excellence (2010) Denosumab for the prevention of osteoporotic fractures in postmenopausal women. NICE Technology Appraisal Guidance 204. NICE, London
20.
National Institute for Health and Clinical Excellence (2012) Osteoporosis: assessing the risk of fragility fracture. NICE Clinical Guideline 146. NICE, London
21.
22.
23.
Strom O, Borgstrom F, Kanis JA, Compston J, Cooper C, McCloskey EV et al (2011) Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 6:59–155PubMedCrossRef
24.
Australian Government (2006) PBS extended listing of alendronate for treating osteoporosis and Medicare extended listing for bone mineral density testing. In Department of Health and Ageing (ed). Canberra
25.
PHARMAC (2012) In: Wilson K, Bloor R, Jennings D (eds) Pharmaceutical schedule. Pharmaceutical Management Agency, Wellington
26.
27.
van Staa TP, Dennison EM, Leufkens HG, Cooper C (2001) Epidemiology of fractures in England and Wales. Bone 29:517–522PubMedCrossRef
28.
U.S. Department of Health and Human Services (2004) Bone health and osteoporosis: a report of the Surgeon General. U.S. Department of Health and Human Services, Office of the Surgeon General, Rockville, MD
29.
Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY, on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57
30.
Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726–1733PubMedCrossRef
31.
Wade SW, Strader C, Fitzpatrick LA, Anthony MS (2012) Sex- and age-specific incidence of non-traumatic fractures in selected industrialized countries. Arch Osteoporos 1–2:219–227
32.
Lesnyak O, Ershova O, Belova K, et al. (2012) Epidemiology of fracture in the Russian Federation and the development of a FRAX model. Arch Osteoporos 1–2:67–73
33.
Xia WB, He SL, Xu L, Liu AM, Jiang Y, Li M et al (2012) Rapidly increasing rates of hip fracture in Beijing, China. J Bone Miner Res 27:125–129PubMedCrossRef
34.
Kanis JA, Johnell O (2005) Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int 16:229–238PubMedCrossRef
35.
Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. doi:10.​1007/​s11657-013-0136-1
36.
Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767PubMedCrossRef
37.
International Osteoporosis Foundation (2009) The Asian Audit: epidemiology, costs and burden of osteoporosis in Asia 2009. IOF, Nyon
38.
Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721–739PubMedCrossRef
39.
Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382PubMedCrossRef
40.
Gallagher JC, Melton LJ, Riggs BL, Bergstrath E (1980) Epidemiology of fractures of the proximal femur in Rochester, Minnesota. Clin Orthop Relat Res 163–171
41.
Port L, Center J, Briffa NK, Nguyen T, Cumming R, Eisman J (2003) Osteoporotic fracture: missed opportunity for intervention. Osteoporos Int 14:780–784PubMedCrossRef
42.
McLellan A, Reid D, Forbes K, Reid R, Campbell C, Gregori A, Raby N, Simpson A (2004) Effectiveness of strategies for the secondary prevention of osteoporotic fractures in Scotland (CEPS 99/03). NHS Quality Improvement Scotland, Glasgow
43.
Edwards BJ, Bunta AD, Simonelli C, Bolander M, Fitzpatrick LA (2007) Prior fractures are common in patients with subsequent hip fractures. Clin Orthop Relat Res 461:226–230PubMed
44.
Black DM, Cummings SR, Karpf DB et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348:1535–1541PubMedCrossRef
45.
McClung MR, Geusens P, Miller PD et al (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 344:333–340PubMedCrossRef
46.
Reginster JY, Seeman E, De Vernejoul MC et al (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90:2816–2822PubMedCrossRef
47.
Rizzoli R, Greenspan SL, Bone G 3rd et al (2002) Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis. J Bone Miner Res 17:1988–1996PubMedCrossRef
48.
Harris ST, Watts NB, Li Z, Chines AA, Hanley DA, Brown JP (2004) Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis. Curr Med Res Opin 20:757–764PubMedCrossRef
49.
Reginster JY, Adami S, Lakatos P et al (2006) Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study. Ann Rheum Dis 65:654–661PubMedCrossRef
50.
McClung MR, Zanchetta JR, Racewicz A, et al. (2012) Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data. Osteoporos Int 24:293–299
51.
Neer RM, Arnaud CD, Zanchetta JR et al (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441PubMedCrossRef
52.
Greenspan SL, Bone HG, Ettinger MP et al (2007) Effect of recombinant human parathyroid hormone (1–84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med 146:326–339PubMedCrossRef
53.
Eisman JA, Civitelli R, Adami S et al (2008) Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study. J Rheumatol 35:488–497PubMed
54.
Cummings SR, San Martin J, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765PubMedCrossRef
55.
Black DM, Delmas PD, Eastell R et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809–1822PubMedCrossRef
56.
Department of Health (2010) Herald Fractures: clinical burden of disease and financial impact. Department of Health, London
57.
Teede HJ, Jayasuriya IA, Gilfillan CP (2007) Fracture prevention strategies in patients presenting to Australian hospitals with minimal-trauma fractures: a major treatment gap. Intern Med J 37:674–679PubMedCrossRef
58.
Papaioannou A, Kennedy CC, Ioannidis G et al (2008) The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporos Int 19:581–587PubMedCrossRef
59.
Smektala R, Endres HG, Dasch B, Bonnaire F, Trampisch HJ, Pientka L (2009) Quality of care after distal radius fracture in Germany. Results of a fracture register of 1,201 elderly patients. Der Unfallchirurg 112:46–54PubMedCrossRef
60.
Carnevale V, Nieddu L, Romagnoli E, Bona E, Piemonte S, Scillitani A et al (2006) Osteoporosis intervention in ambulatory patients with previous hip fracture: a multicentric, nationwide Italian survey. Osteoporos Int 17:478–483PubMedCrossRef
61.
Hagino H, Sawaguchi T, Endo N, Ito Y, Nakano T, Watanabe Y (2012) The risk of a second hip fracture in patients after their first hip fracture. Calcif Tissue Int 90:14–21PubMedCrossRef
62.
Gong HS, Oh WS, Chung MS, Oh JH, Lee YH, Baek GH (2009) Patients with wrist fractures are less likely to be evaluated and managed for osteoporosis. J Bone Joint Surg Am 91:2376–2380PubMedCrossRef
63.
Panneman MJ, Lips P, Sen SS, Herings RM (2004) Undertreatment with anti-osteoporotic drugs after hospitalization for fracture. Osteoporos Int 15:120–124PubMedCrossRef
64.
Suhm N, Lamy O, Lippuner K, OsteoCare study group (2008) Management of fragility fractures in Switzerland: results of a nationwide survey. Swiss Med Wkly 138:674–683PubMed
65.
Royal College of Physicians’ Clinical Effectiveness and Evaluation Unit (2011) Falling standards, broken promises: report of the national audit of falls and bone health in older people 2010. Royal College of Physicians, London
66.
Jennings LA, Auerbach AD, Maselli J, Pekow PS, Lindenauer PK, Lee SJ (2010) Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture. J Am Geriatr Soc 58:650–657PubMedCrossRef
67.
Greenspan SL, Wyman A, Hooven FH et al (2012) Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women. J Am Geriatr Soc 60:455–461PubMedCrossRef
68.
Leslie WD, Giangregorio LM, Yogendran M, Azimaee M, Morin S, Metge C et al (2012) A population-based analysis of the post-fracture care gap 1996–2008: the situation is not improving. Osteoporos Int 23:1623–1629PubMedCrossRef
69.
Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15:767–778PubMedCrossRef
70.
Harrington J (2006) Dilemmas in providing osteoporosis care for fragility fracture patients. US Musculoskelet Rev Touch Brief II:64–65
71.
Chami G, Jeys L, Freudmann M, Connor L, Siddiqi M (2006) Are osteoporotic fractures being adequately investigated?: a questionnaire of GP & orthopaedic surgeons. BMC Fam Pract 7:7PubMedCrossRef
72.
Sale JE, Beaton D, Posen J, Elliot-Gibson V, Bogoch E (2011) Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients. Osteoporos Int 22:2067–2082PubMedCrossRef
73.
British Orthopaedic Association, British Geriatrics Society (2007) The care of patients with fragility fracture, 2nd edn. British Orthopaedic Association, London
74.
Vaile J, Sullivan L, Bennett C, Bleasel J (2007) First Fracture Project: addressing the osteoporosis care gap. Intern Med J 37:717–720PubMedCrossRef
75.
Giles M, Van Der Kallen J, Parker V, Cooper K, Gill K, Ross L et al (2011) A team approach: implementing a model of care for preventing osteoporosis related fractures. Osteoporos Int 22:2321–2328PubMedCrossRef
76.
Kuo I, Ong C, Simmons L, Bliuc D, Eisman J, Center J (2007) Successful direct intervention for osteoporosis in patients with minimal trauma fractures. Osteoporos Int 18:1633–1639PubMedCrossRef
77.
Ward SE, Laughren JJ, Escott BG, Elliot-Gibson V, Bogoch ER, Beaton DE (2007) A program with a dedicated coordinator improved chart documentation of osteoporosis after fragility fracture. Osteoporos Int 18:1127–1136PubMedCrossRef
78.
Majumdar SR, Beaupre LA, Harley CH, Hanley DA, Lier DA, Juby AG et al (2007) Use of a case manager to improve osteoporosis treatment after hip fracture: results of a randomized controlled trial. Arch Intern Med 167:2110–2115PubMedCrossRef
79.
Majumdar SR, Johnson JA, Bellerose D et al (2011) Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: randomized controlled pilot study. Osteoporos Int 22:223–230PubMedCrossRef
80.
Ahmed M, Durcan L, O’Beirne J, Quinlan J, Pillay I (2012) Fracture liaison service in a non-regional orthopaedic clinic—a cost-effective service. Irish Med J 105(24):26–27
81.
Blonk MC, Erdtsieck RJ, Wernekinck MG, Schoon EJ (2007) The fracture and osteoporosis clinic: 1-year results and 3-month compliance. Bone 40:1643–1649PubMedCrossRef
82.
Huntjens KM, van Geel TC, Geusens PP, Winkens B, Willems P, van den Bergh J et al (2011) Impact of guideline implementation by a fracture nurse on subsequent fractures and mortality in patients presenting with non-vertebral fractures. Injury 42(Suppl 4):S39–S43PubMedCrossRef
83.
van Helden S, Cauberg E, Geusens P, Winkes B, van der Weijden T, Brink P (2007) The fracture and osteoporosis outpatient clinic: an effective strategy for improving implementation of an osteoporosis guideline. J Eval Clin Pract 13:801–805PubMedCrossRef
84.
Schurink M, Hegeman JH, Kreeftenberg HG, Ten Duis HJ (2007) Follow-up for osteoporosis in older patients three years after a fracture. Neth J Med 65:71–74PubMed
85.
Carpintero P, Gil-Garay E, Hernandez-Vaquero D, Ferrer H, Munuera L (2009) Interventions to improve inpatient osteoporosis management following first osteoporotic fracture: the PREVENT project. Arch Orthop Trauma Surg 129:245–250PubMedCrossRef
86.
Astrand J, Thorngren KG, Tagil M, Akesson K (2008) 3-year follow-up of 215 fracture patients from a prospective and consecutive osteoporosis screening program. Fracture patients care! Acta orthopaedica 79:404–409PubMedCrossRef
87.
Astrand J, Nilsson J, Thorngren KG (2012) Screening for osteoporosis reduced new fracture incidence by almost half: a 6-year follow-up of 592 fracture patients from an osteoporosis screening program. Acta Orthop 83(6):661–665
88.
Chevalley T, Hoffmeyer P, Bonjour JP, Rizzoli R (2002) An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture. Osteoporos Int 13:450–455PubMedCrossRef
89.
Newman ED, Ayoub WT, Starkey RH, Diehl JM, Wood GC (2003) Osteoporosis disease management in a rural health care population: hip fracture reduction and reduced costs in postmenopausal women after 5 years. Osteoporos Int 14:146–151PubMed
90.
Dell RM, Greene D, Anderson D, Williams K (2009) Osteoporosis disease management: what every orthopaedic surgeon should know. J Bone Joint Surg Am 91(Suppl 6):79–86PubMedCrossRef
91.
Harrington JT, Barash HL, Day S, Lease J (2005) Redesigning the care of fragility fracture patients to improve osteoporosis management: a health care improvement project. Arthritis Rheum 53:198–204PubMedCrossRef
92.
Edwards BJ, Bunta AD, Madison LD, DeSantis A, Ramsey-Goldman R, Taft L et al (2005) An osteoporosis and fracture intervention program increases the diagnosis and treatment for osteoporosis for patients with minimal trauma fractures. Jt Comm J Qual Patient Saf 31:267–274PubMed
93.
Majumdar SR, Lier DA, Beaupre LA, Hanley DA, Maksymowych WP, Juby AG et al (2009) Osteoporosis case manager for patients with hip fractures: results of a cost-effectiveness analysis conducted alongside a randomized trial. Arch Intern Med 169:25–31PubMedCrossRef
94.
McLellan AR, Wolowacz SE, Zimovetz EA, Beard SM, Lock S, McCrink L et al (2011) Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. Osteoporos Int 22:2083–2098PubMedCrossRef
95.
Department of Health (2009) Fracture prevention services: an economic evaluation. Department of Health, London
96.
Marsh D, Akesson K, Beaton DE, Bogoch ER, Boonen S, Brandi ML et al (2011) Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int 22:2051–2065PubMedCrossRef
97.
Eisman JA, Bogoch ER, Dell R et al (2012) Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res 27:2039–2046PubMedCrossRef
98.
99.
Ganda K, Puech M, Chen JS, Speerin R, Bleasel J, Center JR, Eisman JA, March L, Seibel MJ (2013) Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int 24:393–406
100.
Little EA, Eccles MP (2010) A systematic review of the effectiveness of interventions to improve post-fracture investigation and management of patients at risk of osteoporosis. Implement Sci: IS 5:80PubMedCrossRef
101.
102.
Metadata
Title
Capture the Fracture: a Best Practice Framework and global campaign to break the fragility fracture cycle
Authors
K. Åkesson
D. Marsh
P. J. Mitchell
A. R. McLellan
J. Stenmark
D. D. Pierroz
C. Kyer
C. Cooper
IOF Fracture Working Group
Publication date
01-08-2013
Publisher
Springer London
Published in
Osteoporosis International / Issue 8/2013
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-013-2348-z

Other articles of this Issue 8/2013

Osteoporosis International 8/2013 Go to the issue

Original Article

Relationship of thoracic kyphosis and lumbar lordosis to bone mineral density in women

Original Article

The discriminatory capacity of BMD measurements by DXA and dual X-ray and laser (DXL) at the calcaneus including clinical risk factors for detecting patients with vertebral fractures

Original Article

Risk of fracture in patients with Parkinson’s disease

Original Article

Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis

Original Article

Impact of vitamin D fortified milk supplementation on vitamin D status of healthy school children aged 10–14 years

Original Article

Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis